Clinical Cancer Research, Vol 3, Issue 10 1879-1887, Copyright © 1997 by American Association for Cancer Research

ARTICLES

Deregulated expression of p27(Kip1) in human breast cancers

A Sgambato, YJ Zhang, N Arber, H Hibshoosh, Y Doki, M Ciaparrone, RM Santella, A Cittadini and IB Weinstein
Herbert Irving Comprehensive Cancer Center, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.

Protein complexes composed of cyclins and cyclin-dependent kinases control the orderly progression of mammalian cells through the cell cycle. The p27(Kip1) protein belongs to a family of cyclin-dependent kinase-inhibitory proteins that are negative regulators of cell cycle progression and have been proposed as candidate tumor suppressor genes. However, the p27(Kip1) gene is only rarely mutated in human primary breast carcinomas and breast cancer cell lines. To further address the role of p27(Kip1) in the development of human tumors, we determined by Western blot analysis the levels of expression of the p27(Kip1) protein in a series of human cancer cell lines and found that this protein is expressed at high levels in many of these cell lines, even during exponential growth. The levels of p27(Kip1) were significantly associated with the levels of cyclins D1 and E. In contrast to the high level of p27(Kip1) in breast cancer cell lines, three cell lines established from normal mammary epithelium expressed low levels of this protein. Cell synchronization studies demonstrated deregulation of the expression of p27(Kip1) throughout the cell cycle in two breast cancer cell lines but normal regulation in a normal mammary epithelial cell line. Immunohistochemical studies on p27(Kip1) expression in 52 primary human breast cancers indicated that this protein was also expressed at relatively high levels in 44% of the tumor samples, but it was barely detectable or undetectable in the remaining 56% of the samples. Additional studies are required to determine why some breast cancer cells express relatively high levels of p27(Kip1) despite its known role as an inhibitor of cell cycle progression.

This article has been cited by other articles:

				Z. Li, C. Wang, X. Jiao, S. Katiyar, M. C. Casimiro, G. C. Prendergast, M. J. Powell, and R. G. Pestell Alternate Cyclin D1 mRNA Splicing Modulates p27KIP1 Binding and Cell Migration J. Biol. Chem., March 14, 2008; 283(11): 7007 - 7015. [Abstract] [Full Text] [PDF]

				J. Hulit, R. J. Lee, Z. Li, C. Wang, S. Katiyar, J. Yang, A. A. Quong, K. Wu, C. Albanese, R. Russell, et al. p27Kip1 Repression of ErbB2-Induced Mammary Tumor Growth in Transgenic Mice Involves Skp2 and Wnt/{beta}-Catenin Signaling. Cancer Res., September 1, 2006; 66(17): 8529 - 8541. [Abstract] [Full Text] [PDF]

				H. Sonoda, H. Inoue, K. Ogawa, T. Utsunomiya, T.-a. Masuda, and M. Mori Significance of Skp2 Expression in Primary Breast Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1215 - 1220. [Abstract] [Full Text] [PDF]

				H. Wingate, N. Zhang, M. J. McGarhen, I. Bedrosian, J. W. Harper, and K. Keyomarsi The Tumor-specific Hyperactive Forms of Cyclin E Are Resistant to Inhibition by p21 and p27 J. Biol. Chem., April 15, 2005; 280(15): 15148 - 15157. [Abstract] [Full Text] [PDF]

				I. F. Faneyte, J. L. Peterse, H. van Tinteren, C. Pronk, E. G. E. de Vries, S. Rodenhuis, and M. J. van de Vijver Predicting Early Failure after Adjuvant Chemotherapy in High-Risk Breast Cancer Patients with Extensive Lymph Node Involvement Clin. Cancer Res., July 1, 2004; 10(13): 4457 - 4463. [Abstract] [Full Text] [PDF]

				C. Denicourt and S. F. Dowdy Cip/Kip proteins: more than just CDKs inhibitors Genes & Dev., April 15, 2004; 18(8): 851 - 855. [Full Text] [PDF]

				R. M. Harwell, B. B. Mull, D. C. Porter, and K. Keyomarsi Activation of Cyclin-dependent Kinase 2 by Full Length and Low Molecular Weight Forms of Cyclin E in Breast Cancer Cells J. Biol. Chem., March 26, 2004; 279(13): 12695 - 12705. [Abstract] [Full Text] [PDF]

				A A Khan, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, and E-N Lalani Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder Mol. Pathol., December 1, 2003; 56(6): 353 - 361. [Abstract] [Full Text] [PDF]

				Y. Matsuda, T. Ichida, T. Genda, S. Yamagiwa, Y. Aoyagi, and H. Asakura Loss of p16 Contributes to p27 Sequestration by Cyclin D1-Cyclin-dependent Kinase 4 Complexes and Poor Prognosis in Hepatocellular Carcinoma Clin. Cancer Res., August 1, 2003; 9(9): 3389 - 3396. [Abstract] [Full Text] [PDF]

				A. Sgambato, M. Migaldi, M. Montanari, A. Camerini, A. Brancaccio, G. Rossi, R. Cangiano, C. Losasso, G. Capelli, G. P. Trentini, et al. Dystroglycan Expression Is Frequently Reduced in Human Breast and Colon Cancers and Is Associated with Tumor Progression Am. J. Pathol., March 1, 2003; 162(3): 849 - 860. [Abstract] [Full Text] [PDF]

				S. S. McAllister, M. Becker-Hapak, G. Pintucci, M. Pagano, and S. F. Dowdy Novel p27kip1 C-Terminal Scatter Domain Mediates Rac-Dependent Cell Migration Independent of Cell Cycle Arrest Functions Mol. Cell. Biol., January 1, 2003; 23(1): 216 - 228. [Abstract] [Full Text]

				G. Yang, G. Ayala, A. D. Marzo, W. Tian, A. Frolov, T. M. Wheeler, T. C. Thompson, and J. W. Harper Elevated Skp2 Protein Expression in Human Prostate Cancer: Association with Loss of the Cyclin-dependent Kinase Inhibitor p27 and PTEN and with Reduced Recurrence-free Survival Clin. Cancer Res., November 1, 2002; 8(11): 3419 - 3426. [Abstract] [Full Text] [PDF]

				P. O. Chappuis, L. Kapusta, L. R. Begin, N. Wong, J.-S. Brunet, S. A. Narod, J. Slingerland, and W. D. Foulkes Germline BRCA1/2 Mutations and p27Kip1 Protein Levels Independently Predict Outcome After Breast Cancer J. Clin. Oncol., December 15, 2000; 18(24): 4045 - 4052. [Abstract] [Full Text] [PDF]

				D. C. Porter and K. Keyomarsi Novel splice variants of cyclin E with altered substrate specificity Nucleic Acids Res., December 1, 2000; 28(23): e101 - e101. [Abstract] [Full Text] [PDF]

				M. Migaldi, A. Sgambato, L. Garagnani, R. Ardito, P. Ferrari, Carmela De Gaetani, A. Cittadini, and G. P. Trentini Loss of p21Waf1 Expression Is a Strong Predictor of Reduced Survival in Primary Superficial Bladder Cancers Clin. Cancer Res., August 1, 2000; 6(8): 3131 - 3138. [Abstract] [Full Text]

				I.B. Weinstein Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis Carcinogenesis, May 1, 2000; 21(5): 857 - 864. [Abstract] [Full Text] [PDF]

				M. Sanchez-Beato, F. I. Camacho, J. C. Martinez-Montero, A. I. Saez, R. Villuendas, L. Sanchez-Verde, J. F. Garcia, and M. A. Piris Anomalous High p27/KIP1 Expression in a Subset of Aggressive B-Cell Lymphomas Is Associated With Cyclin D3 Overexpression. p27/KIP1---Cyclin D3 Colocalization in Tumor Cells Blood, July 15, 1999; 94(2): 765 - 772. [Abstract] [Full Text] [PDF]

				A. Sgambato, M. Migaldi, B. Faraglia, L. Garagnani, G. Romano, C. De Gaetani, P. Ferrari, G. Capelli, G. P. Trentini, and A. Cittadini Loss of P27Kip1 Expression Correlates with Tumor Grade and with Reduced Disease-free Survival in Primary Superficial Bladder Cancers Cancer Res., July 1, 1999; 59(13): 3245 - 3250. [Abstract] [Full Text] [PDF]

				H. Yamamoto, J.-W. Soh, T. Monden, M. G. Klein, L. M. Zhang, H. Shirin, N. Arber, N. Tomita, I. Schieren, C. A. Stein, et al. Paradoxical Increase in Retinoblastoma Protein in Colorectal Carcinomas May Protect Cells from Apoptosis Clin. Cancer Res., July 1, 1999; 5(7): 1805 - 1815. [Abstract] [Full Text] [PDF]

				R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers Am. J. Pathol., February 1, 1999; 154(2): 313 - 323. [Abstract] [Full Text] [PDF]

				L. Quintanilla-Martinez, C. Thieblemont, F. Fend, S. Kumar, M. Pinyol, E. Campo, E. S. Jaffe, and M. Raffeld Mantle Cell Lymphomas Lack Expression of p27kip1, a Cyclin-Dependent Kinase Inhibitor Am. J. Pathol., July 1, 1998; 153(1): 175 - 182. [Abstract] [Full Text] [PDF]